Info

Automated Cell, Inc is focused on the discovery and development of monoclonal antibody therapeutics for the treatment of cancer. Our unique and proprietary technology allows us to rapidly and inexpensively identify human antibodies that have relevant biological function in a specific disease. Our approach is target-independent and does not require prior knowledge of the target or mechanism. We anticipate that many of the targets we find will be novel. We will drive our product candidates through the clinic and out-license certain pipeline candidates to pharmaceutical partners.